keyword
https://read.qxmd.com/read/38645669/costs-of-air-pollution-in-california-s-san-joaquin-valley-a-societal-perspective-of-the-burden-of-asthma-on-emergency-departments-and-inpatient-care
#1
JOURNAL ARTICLE
Gilda Zarate-Gonzalez, Paul Brown, Ricardo Cisneros
INTRODUCTION: The San Joaquin Valley (SJV) is often recognized as one of the most polluted regions in the US. Periods of pollution exposure are associated with increased health burden related to respiratory inflammation and undermined lung function, which aggravates respiratory diseases such as asthma and leads to symptoms such as coughing, wheezing, or difficulty breathing. Asthma costs US$ 82 billion annually in healthcare costs, missed work and school in the US. METHODS: Employing a societal perspective, a cost of illness design was combined with environmental epidemiological methods to analyze the economic impact of O3 , NO2 , and PM2...
2024: Journal of Asthma and Allergy
https://read.qxmd.com/read/38642637/long-term-exposure-to-ambient-ozone-and-adult-onset-asthma-a-prospective-cohort-study
#2
JOURNAL ARTICLE
Jiayue Zhang, Baozhuo Ai, Yuming Guo, Lan Chen, Ge Chen, Haitao Li, Hualiang Lin, Zilong Zhang
BACKGROUND: The association between long-term exposure to ozone (O3 ) and adult-onset asthma (AOA) remains inconclusive, and analysis of causality is lacking. OBJECTIVES: To examine the causal association between long-term O3 exposure and AOA. METHODS: A prospective cohort study of 362,098 participants was conducted using the UK Biobank study. Incident cases of AOA were identified using health administrative data of the National Health Services...
April 18, 2024: Environmental Research
https://read.qxmd.com/read/38637911/long-term-impairment-from-irritant-induced-occupational-asthma
#3
JOURNAL ARTICLE
Jussi Lantto, Hille Suojalehto, Tuula Vasankari, Kirsi Karvala, Irmeli Lindström
OBJECTIVE: To assess the long-term physical condition, health-related quality of life, employment, and work ability of irritant-induced asthma (IIA) patients. METHODS: Forty-three IIA patients completed a follow-up questionnaire a median of eight (interquartile range 4-11) years after asthma diagnosis. We compared their results with those of 43 low-molecular-weight (LMW) sensitizer-induced occupational asthma (OA) patients and those of 206 adult-onset asthmatics in the general population...
April 22, 2024: Journal of Occupational and Environmental Medicine
https://read.qxmd.com/read/38637815/variability-in-the-prevalence-of-depression-among-adults-with-chronic-pain-uk-biobank-analysis-through-clinical-prediction-models
#4
JOURNAL ARTICLE
Lingxiao Chen, Claire E Ashton-James, Baoyi Shi, Maja R Radojčić, David B Anderson, Yujie Chen, David B Preen, John L Hopper, Shuai Li, Minh Bui, Paula R Beckenkamp, Nigel K Arden, Paulo H Ferreira, Hengxing Zhou, Shiqing Feng, Manuela L Ferreira
BACKGROUND: The prevalence of depression among people with chronic pain remains unclear due to the heterogeneity of study samples and definitions of depression. We aimed to identify sources of variation in the prevalence of depression among people with chronic pain and generate clinical prediction models to estimate the probability of depression among individuals with chronic pain. METHODS: Participants were from the UK Biobank. The primary outcome was a "lifetime" history of depression...
April 19, 2024: BMC Medicine
https://read.qxmd.com/read/38636990/the-association-of-blood-eosinophil-counts-and-fev-1-decline-a-cohort-study
#5
JOURNAL ARTICLE
Yun Soo Hong, Hye Yun Park, Seungho Ryu, Sun Hye Shin, Di Zhao, Dave Singh, Eliseo Guallar, Juhee Cho, Yoosoo Chang, Seong Yong Lim
BACKGROUND: Accelerated lung function decline is characteristic of chronic obstructive pulmonary disease (COPD). However, the association between blood eosinophil counts and lung function decline, accounting for current smoking status, in young individuals without prevalent lung disease is not fully understood. METHODS: This is a cohort study of 629 784 Korean adults without COPD or a history of asthma at baseline who participated in health screening examinations including spirometry and differential white blood cell counts...
April 18, 2024: European Respiratory Journal
https://read.qxmd.com/read/38636683/asthma-patients-and-physicians-perspectives-on-the-burden-and-management-of-asthma-post-hoc-analysis-of-apparent-1-and-2-to-assess-predictors-of-treatment-adherence
#6
JOURNAL ARTICLE
Giorgio Walter Canonica, Christian Domingo, Kim L Lavoie, Amrit Kaliasethi, Shireen Quli Khan, Anurita Majumdar, Sourabh Fulmali
INTRODUCTION: Patient adherence to maintenance medication is critical for improving clinical outcomes in asthma and is a recommended guiding factor for treatment strategy. Previously, the APPaRENT studies assessed patient and physician perspectives on asthma care; here, a post-hoc analysis aimed to identify patient factors associated with good adherence and treatment prescription patterns. METHODS: APPaRENT 1 and 2 were cross-sectional online surveys of 2866 adults with asthma and 1883 physicians across Argentina, Australia, Brazil, Canada, China, France, Italy, Mexico, and the Philippines in 2020-2021...
April 16, 2024: Respiratory Medicine
https://read.qxmd.com/read/38635834/biomarker-predictors-of-clinical-efficacy-of-the-anti-ige-biologic-omalizumab-in-severe-asthma-in-adults-results-of-the-somosa-study
#7
JOURNAL ARTICLE
Ratko Djukanović, Paul Brinkman, Johan Kolmert, Cristina Gomez, James Schofield, Joost Brandsma, Andy Shapanis, Paul J S Skipp, Anthony Postle, Craig Wheelock, Sven-Erik Dahlen, Peter J Sterk, Thomas Brown, David J Jackson, Adel Mansur, Ian Pavord, Mitesh Patel, Christopher Brightling, Salman Siddiqui, Peter Bradding, Ian Sabroe, Dinesh Saralaya, Livingstone Chishimba, Joanna Porter, Douglas Robinson, Stephen Fowler, Peter H Howarth, Louisa Little, Thomas Oliver, Kayleigh Hill, Louise Stanton, Alexander Allen, Deborah Ellis, Gareth Griffiths, Tim Harrison, Ayobami Akenroye, Jessica Lasky-Su, Liam Heaney, Rekha Chaudhuri, Ramesh Kurukulaaratchy
BACKGROUND: The anti-IgE monoclonal, omalizumab, is widely used for severe asthma. This study aimed to identify biomarkers that predict clinical improvement during one year of omalizumab treatment. METHODS: 1-year, open-label, S tudy o f M echanisms of action of O malizumab in S evere A sthma ( SoMOSA ) involving 216 severe (GINA step 4/5) uncontrolled atopic asthmatics (≥2 severe exacerbations in previous year) on high-dose inhaled corticosteroids, long-acting β-agonists, ± mOCS...
April 18, 2024: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38632826/population-pharmacokinetic-modeling-and-exposure-efficacy-and-body-weight-response-analyses-for-tezepelumab-in-patients-with-severe-uncontrolled-asthma
#8
JOURNAL ARTICLE
Yanan Zheng, Lubna Abuqayyas, Angelica Quartino, Ye Guan, Yuying Gao, Lu Liu, Åsa Hellqvist, Gene Colice, Alexander MacDonald
Tezepelumab is a human monoclonal antibody that blocks the activity of thymic stromal lymphopoietin. This analysis assessed the suitability of a fixed-dose regimen of tezepelumab 210 mg every 4 weeks (Q4W) in adults and adolescents with severe, uncontrolled asthma. A population pharmacokinetic model was developed using data from 1368 patients with asthma or healthy participants enrolled in 8 clinical studies (phases 1-3). Tezepelumab exposure-efficacy relationships were analyzed in the phase 3 NAVIGATOR study (NCT03347279), using asthma exacerbation rates over 52 weeks and changes in pre-bronchodilator forced expiratory volume in 1 s at week 52...
April 17, 2024: Journal of Clinical Pharmacology
https://read.qxmd.com/read/38631523/association-of-socioeconomic-status-and-a-broad-combination-of-lifestyle-factors-with-adult-onset-asthma-a-cohort-study
#9
JOURNAL ARTICLE
Zina Fan, Minzhi Xu, Shanquan Chen, Jing Wang, Yanhong Gong, Xinglin Feng, Xiaoxv Yin
BACKGROUND: The prevalence of asthma is gradually increasing worldwide and there are socioeconomic inequalities in the risk of developing asthma. OBJECTIVE: This study aimed to evaluate whether the lifestyle is associated with asthma in adults, as well as whether and to what extent healthy lifestyles may modify socioeconomic status (SES) inequities in asthma. METHODS: This study included a total of 223951 participants from the UK Biobank. Smoking, physical activity, alcohol consumption, healthy diet patterns, sedentary time, and sleep duration items were used to construct the lifestyle score...
April 15, 2024: Journal of Allergy and Clinical Immunology in Practice
https://read.qxmd.com/read/38630374/geo-visualizing-the-hotspots-of-smog-induced-health-effects-in-district-gujranwala-pakistan-a-community-perspective
#10
JOURNAL ARTICLE
Shakeel Mahmood, Aqib Ali, Huda Jamal Jumaah
This study aims to examine the health effects of smog on different age groups in Gujranwala and its associated health effects. To achieve this, primary data was gathered through a questionnaire survey focused on health issues faced by elderly individuals during the smog season. The results of the survey revealed that older adults in Gujranwala are particularly vulnerable to a range of health problems during this period, including coughing, throat infections, irritated eyes, runny noses, shortness of breath, chest pain while breathing, wheezing, asthma, heart problems, and respiratory issues...
April 17, 2024: Environmental Monitoring and Assessment
https://read.qxmd.com/read/38626928/validity-and-reliability-of-outcome-measures-to-assess-dysfunctional-breathing-a-systematic-review
#11
JOURNAL ARTICLE
Vikram Mohan, Chandrasekar Rathinam, Derick Yates, Aatit Paungmali, Christopher Boos
OBJECTIVE: This study aimed to systematically review the psychometric properties of outcome measures that assess dysfunctional breathing (DB) in adults. METHODS: Studies on developing and evaluating measurement properties to assess DB were included. The study investigated the empirical research published between 1990 and February 2022, with an updated search in May 2023 in the Cochrane Library database of systematic reviews and the Cochrane Central Register of Controlled Trials, the Ovid Medline (full), the Ovid Excerta Medica Database, the Ovid allied and complementary medicines database, the Ebscohost Cumulative Index to Nursing and Allied Health Literature and the Physiotherapy Evidence Database...
April 16, 2024: BMJ Open Respiratory Research
https://read.qxmd.com/read/38623320/respiratory-allergic-diseases-and-allergen-immunotherapy-a-french-patient-survey-before-and-during-the-covid-19-pandemic
#12
JOURNAL ARTICLE
Philippe Devillier, Sarah Saf, Christine Rolland, Giorgio Walter Canonica, Pascal Demoly
BACKGROUND: The COVID-19 pandemic brought unprecedented global disruption to both healthcare providers and patients with respiratory allergies. There are limited real-life data on the impact of the COVID-19 pandemic on the risk perception of patients with allergy treated with allergen immunotherapy (AIT). OBJECTIVE: To understand the risk perception of allergic patients treated with sublingual immunotherapy (SLIT) before and during the pandemic, and their attitudes towards COVID-19 infection and vaccination...
April 2024: World Allergy Organization Journal
https://read.qxmd.com/read/38621429/a-nationwide-study-on-immunosenescence-biomarkers-profile-in-older-adults-elsi-brazil
#13
JOURNAL ARTICLE
Maria Luiza Lima-Silva, Karen Cecília Lima Torres, Juliana Vaz de Melo Mambrini, Nathalia Coimbra de Brot, Sara de Oliveira Santos, Olindo Assis Martins-Filho, Andréa Teixeira-Carvalho, Maria Fernanda Lima-Costa, Sérgio Viana Peixoto
Immunosenescence is a phenomenon caused by changes in the immune system, and part of these changes involves an increase in circulating immunological biomarkers, a process known as "Inflammaging." Inflammaging can be associated with many diseases related to older people. As the older population continues to grow, understanding changes in the immune system becomes essential. While prior studies assessing these alterations have been conducted in countries with Caucasian populations, this investigation marks a pioneering effort...
April 13, 2024: Experimental Gerontology
https://read.qxmd.com/read/38621405/safety-of-a-controlled-human-infection-model-of-tuberculosis-with-aerosolised-live-attenuated-mycobacterium-bovis-bcg-versus-intradermal-bcg-in-bcg-naive-adults-in-the-uk-a-dose-escalation-randomised-controlled-phase-1-trial
#14
JOURNAL ARTICLE
Iman Satti, Julia L Marshall, Stephanie A Harris, Rachel Wittenberg, Rachel Tanner, Raquel Lopez Ramon, Morven Wilkie, Fernando Ramos Lopez, Michael Riste, Daniel Wright, Marco Polo Peralta Alvarez, Nicola Williams, Hazel Morrison, Elena Stylianou, Pedro Folegatti, Daniel Jenkin, Samantha Vermaak, Linnea Rask, Ingrid Cabrera Puig, Rebecca Powell Doherty, Alison Lawrie, Paul Moss, Timothy Hinks, Henry Bettinson, Helen McShane
BACKGROUND: Mycobacterium tuberculosis is the main causative agent of tuberculosis. BCG, the only licensed vaccine, provides inadequate protection against pulmonary tuberculosis. Controlled human infection models are useful tools for vaccine development. We aimed to determine a safe dose of aerosol-inhaled live-attenuated Mycobacterium bovis BCG as a surrogate for M tuberculosis infection, then compare the safety and tolerability of infection models established using aerosol-inhaled and intradermally administered BCG...
April 12, 2024: Lancet Infectious Diseases
https://read.qxmd.com/read/38619468/advancements-in-biologic-therapy-in-eosinophilic-asthma
#15
REVIEW
Rini Patadia, Thomas B Casale, John Fowler, Shiven Patel, Juan Carlos Cardet
INTRODUCTION: Asthma encompasses a spectrum of phenotypes often categorized into two groups- type 2 high (T2 high) and type 2 low (T2 low). T2 high includes atopic and eosinophilic presentations whereas T2 low is non-atopic, non-eosinophilic, and oft associated with neutrophilic inflammation. Eosinophilic asthma is often driven by IgE, IL-4, IL-5, and IL-13 and TSLP. This can lead to eosinophilic inflammatory response in the airways which in turn can be used as target for treatment. AREAS COVERED: The article will focus on biologic therapy that is currently being used in eosinophilic asthma management in mainly the adult population including clinical trials and co-morbidities that can be treated using the same biologics...
April 15, 2024: Expert Opinion on Biological Therapy
https://read.qxmd.com/read/38619130/clinical-findings-and-outcome-predictors-for-multinodular-pulmonary-fibrosis-in-horses-46-cases-2009-2019
#16
JOURNAL ARTICLE
Amanda Craven, Amy Todd-Donato, Tracy Stokol, Rachel Liepman, Ilana Glasberg, Pamela Wilkins, Daniela Luethy, David Wong, Angelika Schoster, Astrid J van den Brom-Spierenburg, Joy E Tomlinson
BACKGROUND: Prognostic indicators for equine multinodular pulmonary fibrosis (EMPF), an interstitial fibrosing lung disease, are poorly described. HYPOTHESIS/OBJECTIVES: Describe diagnostic findings and outcome predictors for EMPF. ANIMALS: Forty-six adult horses with EMPF. METHODS: Retrospective multicenter case series from 2009 to 2019. Radiographic (n = 27) and ultrasonographic studies (n = 19) from EMPF horses and bronchoalveolar lavage fluid (BALF) cytology from 6 EMPF and 13 asthma cases were independently reviewed and blinded to diagnosis and outcome...
April 15, 2024: Journal of Veterinary Internal Medicine
https://read.qxmd.com/read/38615737/8-iso-prostaglandin-f2%C3%AE-as-a-biomarker-of-t2-low-airway-inflammation-and-remodeling-in-adult-asthma
#17
JOURNAL ARTICLE
Seong-Dae Woo, Hee Sun Park, Eun-Mi Yang, Ga-Young Ban, Hae-Sim Park
BACKGROUND: Although 8-iso-prostaglandin F2a has been proposed as a potential biomarker for oxidative stress in airway diseases, its specific role in asthma remains poorly understood. OBJECTIVE: To evaluate the diagnostic potential of 8-iso-prostaglandin F2a in assessing airway inflammation, airway remodeling, airway hyperresponsiveness, and oxidative stress in asthma. METHODS: Blood and urine concentrations of 8-iso-prostaglandin F2a were quantified using liquid chromatography-tandem mass spectrometry in 128 adults with asthma who had maintained anti-asthmatic medications...
April 12, 2024: Annals of Allergy, Asthma & Immunology
https://read.qxmd.com/read/38614697/opportunistic-optimisation-of-inhaler-technique-in-hospitalised-adults-with-asthma-a-two-phase-quality-improvement-project
#18
JOURNAL ARTICLE
Mrinalini Dey, Koushan Kouranloo, Joseph Hanna, Ananya Singh, Alice Rafferty, Stephen Scott
No abstract text is available yet for this article.
November 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38613765/the-experience-of-shared-decision-making-for-people-with-asthma-a-systematic-review-and-metasynthesis-of-qualitative-studies
#19
REVIEW
Hui-Qi Kang, Yueming Pen, Yuanyuan He, Xiufen Yang, Jin Su, Qiaohong Yang, Weixiang Luo
OBJECTIVES: To identify, describe and synthesise the views and experiences of adults living with asthma regarding shared decision-making (SDM) in the existing qualitative literature METHODS: We conducted a comprehensive search of 10 databases (list databases) from inception until September 2023. Screening was performed according to inclusion criteria. Tools from the Joanna Briggs lnstitute were utilised for the purposes of data extraction and synthesis in this study. The data extraction process in this study employed the Capability, Opportunity and Motivation Model of Behaviour (COM-B model) as a framework, and a pragmatic meta-aggregative approach was employed to synthesise the collected results...
April 2024: Health Expectations: An International Journal of Public Participation in Health Care and Health Policy
https://read.qxmd.com/read/38609096/the-carbon-footprint-of-as-needed-budesonide-formoterol-in-mild-asthma-a-post-hoc-analysis
#20
JOURNAL ARTICLE
Lee Hatter, Mark Holliday, Allie Eathorne, Pepa Bruce, Ian D Pavord, Helen K Reddel, Robert J Hancox, Alberto Papi, Mark Weatherall, Richard Beasley
INTRODUCTION: The use of pressurised metered-dose inhalers (pMDIs) and asthma exacerbations necessitating healthcare reviews contribute substantially to the global carbon footprint of healthcare. It is possible that a reduction in carbon footprint could be achieved by switching patients with mild asthma from salbutamol pMDI reliever therapy to inhaled corticosteroid-formoterol dry powder inhaler (DPI) reliever therapy, as recommended by the Global Initiative for Asthma (GINA). METHODS: This post hoc analysis included all 668 adult participants in the Novel START trial, who were randomised 1:1:1 to treatment with: as-needed budesonide-formoterol DPI, as-needed salbutamol pMDI, or maintenance budesonide DPI plus as-needed salbutamol pMDI...
April 12, 2024: European Respiratory Journal
keyword
keyword
107735
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.